| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 09/13/2007 | WO2007103456A2 Piperazine and piperidine biaryl derivatives |
| 09/13/2007 | WO2007102501A1 Polymerizable spherical transition metal complexes, spherical transition metal complexes, and processes for the production of both |
| 09/13/2007 | WO2007101573A1 Substituted arylsulfonamides as antiviral agents |
| 09/13/2007 | WO2007071766A3 Phenoxy acetic acids as ppar delta activators |
| 09/13/2007 | US20070213377 2-{4-[Ethyl-(thiazol-4-ylmethyl)-amino]-phenyl}-1,1,1,3,3,3-hexafluoro-propan-2-ol; liver-X-receptor modulators; anticholesterol agents; antiinflammatory agents; atherosclerosis; dyslipidemia; antidiabetic agents; alzheimer's disease; sepsis; skin disorders; cognition modulators |
| 09/13/2007 | US20070213374 Malonamide Derivatives |
| 09/13/2007 | US20070213372 Substituted 2, 6-diamino-3, 5-dicyano-4-arylpyridines and their use as adenosine-receptor-selective ligands |
| 09/13/2007 | US20070213364 Alkoxyphenylpropanoic Acid Derivatives |
| 09/13/2007 | US20070213348 Chemical Compounds |
| 09/13/2007 | US20070213336 peroxisome proliferator activated receptor agonists, such as (E)-3-[3'-(3-heptyl-1-methylureido)biphenyl-4-yl]acrylic acid, useful in human or veterinary medicine (in dermatology, cardiovascular diseases, immune diseases and/or metabolism of lipids); cosmetics |
| 09/13/2007 | US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
| 09/13/2007 | US20070213329 Sulphones which modulate the action of gammasecretase |
| 09/13/2007 | US20070213323 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 09/13/2007 | US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/13/2007 | US20070213299 pyridinium salts such as 1-ethyl-(E,E)-2,6-bis[2-[4-(dimethylamino)phenyl]ethenyl]pyridinium chloride, used as fungicides, bactericides or insecticides on a substrate ( lumber, decking, flooring, roofing, carpets, wallpaper, paneling, cloth caulking etc.); encapsulated, sustained release |
| 09/13/2007 | US20070213210 Process for the production of hetreroaromatic nitriles, improved catalyst therefor and a process for the production of said improved catalyst |
| 09/13/2007 | US20070209695 Dye and Dye-Sensitized Solar Cell |
| 09/13/2007 | CA2642602A1 Substituted arylsulfonamides as antiviral agents |
| 09/12/2007 | EP1832578A1 Method for producing thiocarbamate derivative |
| 09/12/2007 | EP1831198A1 Pyridine carboxamide derivatives for use as anticancer agents |
| 09/12/2007 | EP1831188A1 N-biaryl and n-arylheteroaryl 2-substituted piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 09/12/2007 | EP1831184A2 Pyrazines and pyridines and derivatives thereof as therapeutic compounds |
| 09/12/2007 | EP1831179A1 Method for the production of onium salts with tetrafluoroborate anion having a reduced halide content |
| 09/12/2007 | EP1831170A1 Substituted aminopyridines and uses thereof |
| 09/12/2007 | EP1831169A2 Process for the preparation of a 2-pyridylethylcarboxamide derivative |
| 09/12/2007 | EP1831168A1 Pyrid-2-ones useful as inhibitors of tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases. |
| 09/12/2007 | EP1831167A1 Liquid phase process for the synthesis of annulated pyridines over zeolite type molecular sieve catalysts |
| 09/12/2007 | EP1831157A2 Nonnucleoside inhibitors of hiv-1 reverse transcriptase |
| 09/12/2007 | EP1737840B1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof |
| 09/12/2007 | EP1558580B1 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents |
| 09/12/2007 | EP1558579B1 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials |
| 09/12/2007 | EP1379239B1 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
| 09/12/2007 | EP1296952B1 Benzoylpyridine derivative or its salt, fungicide containing it as an active ingredient, its production process and intermediate for producing it |
| 09/12/2007 | EP1019358B2 3,3-diarylpropylamines , their use and preparation |
| 09/12/2007 | CN101035774A Modulators of CRTH-2 receptor activity for the treatment of prostaglandin D2 mediated diseases |
| 09/12/2007 | CN101035763A Process for producing heteroaromatic carboxylic acids |
| 09/12/2007 | CN101035762A Alkil-pyridines as 11-beta inhibitors for diabetes |
| 09/12/2007 | CN101035761A 3,6-substituted 5-arylamino-1h-pyridine-2-one derivatives and related compounds as poly(ADP-ribose) polymerase(PARP) inhibitors in the treatment of tissue damage or diseage caused by necrosis or apopt |
| 09/12/2007 | CN101035760A Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 09/12/2007 | CN101035533A Dual NK1/NK3 antagonists against schizophrenia |
| 09/12/2007 | CN101033212A Method for preparing 4-dimethylaminopyridine |
| 09/12/2007 | CN101033211A 5-chloro-4-hydroxy-2(1H)-pyridone and its preparation method and applicaiton |
| 09/12/2007 | CN101033210A Functionalization acidic ionic liquid based on pyridine cation and its synthetic method and application |
| 09/12/2007 | CN101032693A Catalyst for producing pyridine alkali and its preparation method |
| 09/12/2007 | CN100336808C Substituted pyridyloxyalkylamides and their use as fungicides |
| 09/12/2007 | CN100336807C Benzoylpyridine drivative or its salt, fungicide containing it as active ingredient, its production process and intermediate for producing it |
| 09/12/2007 | CN100336794C N-arylation process with hydrazone as ligand in aqueous phase system |
| 09/11/2007 | US7268365 Porous solid of copper, silicon wafers, or silicon dioxide coated with a barrier layer with a complex of a substituted diimine or diamine propyl group |
| 09/11/2007 | US7268249 Reacting hydroquinone or a salt thereof with a S-2-halopropanoic acid or a salt thereof in the presence of a mild reducing agent |
| 09/11/2007 | US7268166 Substituted 4-phenyl amino butane; spinal chord injuries, neuroprotectants, anticonvulsants, anxiolytics, analgesics, muscle relaxants or adjuvants to general anesthetics |
| 09/11/2007 | US7268157 Substituted arylalcanoic acid derivatives as PPAR pan agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 09/11/2007 | US7268153 N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
| 09/11/2007 | US7268152 Antiinflammatory agents; antiallergens; antiproliferative agents |
| 09/11/2007 | US7268147 For therapy of inflammatory, allergic and respiratory diseases |
| 09/11/2007 | US7268135 Biaryl sulfonamides and methods for using same |
| 09/11/2007 | US7268132 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder |
| 09/11/2007 | CA2433839C Primary intermediates for oxidative coloration of hair |
| 09/11/2007 | CA2318368C Novel tricyclic compound |
| 09/11/2007 | CA2255858C Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers |
| 09/11/2007 | CA2231975C Substituted amino compounds and their use as substances having an analgesic effect |
| 09/11/2007 | CA2070419C Synthesis and use of amino acid fluorides as peptide coupling reagents |
| 09/07/2007 | WO2007099385A1 Dipeptidyl peptidase iv inhibitor compounds and compositions |
| 09/07/2007 | WO2007098826A2 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 09/07/2007 | WO2007083090A3 Process for the preparation of uracil derivatives |
| 09/07/2007 | WO2007075688A3 Substituted aniline derivatives useful as histamine h3 antagonists |
| 09/07/2007 | WO2007011760A3 Inhibitors of mitotic kinesin |
| 09/07/2007 | CA2642424A1 Primary amines as renin inhibitors |
| 09/07/2007 | CA2637530A1 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 09/06/2007 | US20070208181 reduced or no emetogenic effects ; benzylated phosphodiesterase 4 inhibitors; e.g. Rolipram, Ariflo, Arofylline; preparation by benzylation using benzyl bromide or a derivative; antiinflammatory agents; to treat autoimmune diseases; cystic fibrosis |
| 09/06/2007 | US20070208180 Process for Preparation of Nonnatural Amino Acid and Intermediate Thereof |
| 09/06/2007 | US20070208166 Tao Kinase Modulators And Method Of Use |
| 09/06/2007 | US20070208112 Use of Pyridindione Derivatives for Protecting Organic Material Against Detrimental Effects of Light |
| 09/06/2007 | US20070208046 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders |
| 09/06/2007 | US20070208026 N-Containing Heteroaromatic Compounds As Modulators Of Ppars And Methods Of Treating Metabolic Disorders |
| 09/06/2007 | US20070208025 Novel pyridazine derivatives and medicines containing the same as effective ingredients |
| 09/06/2007 | US20070207175 Biaromatic compound activators of PPARgamma receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 09/05/2007 | EP1829865A2 Chemical compounds |
| 09/05/2007 | EP1829863A1 Arylalkanoic acid derivative |
| 09/05/2007 | EP1829858A2 Dibenzylamine compounds and pharmaceutical use thereof |
| 09/05/2007 | EP1829856A2 Transfection reagents |
| 09/05/2007 | EP1828160A1 Sulfonyl amino cyclic derivatives and use thereof as mmp inhibitors |
| 09/05/2007 | EP1828156A2 N-biaryl and n-arylheteroaryl piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 09/05/2007 | EP1828142A1 Method for producing onium alkyl sulfates with a low halogenide content |
| 09/05/2007 | EP1828134A1 Piperazinyl pyridine derivatives as anti-obesity agents |
| 09/05/2007 | EP1828133A2 Methylene inhibitors of matrix metalloproteinase |
| 09/05/2007 | EP1828132A1 Pyridine ketones with herbicidal effect |
| 09/05/2007 | EP1827501A2 Stabilized polymeric thiol reagents |
| 09/05/2007 | EP1689698A4 Bis-cationic compounds and use thereof |
| 09/05/2007 | EP1633715B1 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamine derivatives as beta 2-adrenoceptors agonists |
| 09/05/2007 | EP1521753B1 A process to prepare pioglitazone via several intermediates. |
| 09/05/2007 | EP1373233B1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 09/05/2007 | EP1057815B1 Cyclic amide compounds |
| 09/05/2007 | EP0993452B1 Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 09/05/2007 | CN101031547A Cyclopropyl piperidine glycine transporter inhibitors |
| 09/05/2007 | CN101031541A 4-aminomethyl benzamidine derivatives and their use as factor viia inhibitors |
| 09/05/2007 | CN101031539A Substituted arylalkanoic acid derivatives and use thereof |
| 09/05/2007 | CN101029023A Production of picolyl ether and its salt |
| 09/05/2007 | CN101029022A Process for the preparation of 4-phenoxy quinoline derivatives |
| 09/05/2007 | CN101029021A Production of 2,6-diamino-pyridine |
| 09/05/2007 | CN101029020A Polysubstituted phenol derivative and its production |